[1] From birth to adulthood in rural Ethiopia: the Butajira Birth Cohort of 1987

[2] Efficacy and safety of recombinant human activated protein C for severe sepsis

[3] Childhood malaria in a region of unstable transmission and high human immunodeficiency virus prevalence

[4] The sentinel node concept in endometrial cancer: histopathologic validation by serial section and immunohistochemistry

[5] Significance of FLT3-tyrosine kinase domain mutation as a prognostic factor for acute myeloid leukemia

[6] First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial

[7] The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

[8] Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy

[9] Levofloxacin cures experimental pneumonic plague in African green monkeys

[10] Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis

[11] Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol

[12] Prognostic Value of Adjuvant Chemotherapy Following Pancreaticoduodenectomy in Elderly Patients With Pancreatic Cancer

[13] Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis

[14] Dengue hemophagocytic syndrome: A systematic review and meta-analysis on epidemiology, clinical signs, outcomes, and risk factors

[15] Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients

[16] Pharmacodynamics of levofloxacin and ciprofloxacin in a murine pneumonia model: peak concentration/MIC versus area under the curve/MIC ratios

[17] applied the additive hazard model to predict the survival time of patient with diffuse large b- cell lymphoma and determine the effective genes, using microarray data

[18] Encephalopathy and progression of human immunodeficiency virus disease in a cohort of children with perinatally acquired human immunodeficiency virus infection. Women and Infants Transmission Study Group

[19] Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus

[20] A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)

[21] Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults

[22] Histoplasma capsulatum utilizes siderophores for intracellular iron acquisition in macrophages

[23] Epidemic increase in Salmonella bloodstream infection in children, Bwamanda, the Democratic Republic of Congo

[24] Retrospective survey to evaluate the safety and efficacy of Japanese botulinum antitoxin therapy in Japan

[25] A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C

[26] Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice

[27] Predicting functional outcome and survival after acute ischemic stroke

[28] Left Ventricular Aneurysm Repair: Off-pump Linear Plication versus On-pump Patch Plasty

[29] Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial

[30] Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial

[31] Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

[32] Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: a comparison of methods

[33] Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)

[34] Estimate risk difference and number needed to treat in survival analysis.

[35] Why newly graduated nurses in South Korea leave their first job in a short time? A survival analysis.

[36] Malnutrition as predictor of survival from anti-retroviral treatment among children living with HIV/AIDS in Southwest Ethiopia: survival analysis.

[37] A new semi-supervised learning model combined with Cox and SP-AFT models in cancer survival analysis

[38] BMI is an independent prognostic factor for late outcome in patients diagnosed with early breast cancer: A landmark survival analysis

[39] brazil’s simplified tax regime and the longevity of brazilian manufacturing companies: a survival analysis based on rais microdata

[40] intensity-modulated ventricular irradiation for intracranial germ-cell tumors: survival analysis and impact of salvage re-irradiation.

[41] estimation of unemployment duration in botoşani county using survival analysis

[42] chemotherapy and egfr tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients

[43] ocorrência de neurite em pacientes com hanseníase: análise de sobrevida e fatores preditivos occurrence of neuritis among leprosy patients: survival analysis and predictive factors

[44] liver morphology with emphasis on bile ducts changes and survival analysis in mice submitted to multiple schistosoma mansoni infections and chemotherapy alterações morfológicas hepáticas, com especial ênfase nas alterações dos ductos biliares e an��lise de sobrevivência em camundongos submetidos a infecções múltiplas por s. mansoni e a quimioterapia

[45] an introduction to survival analysis using stata

[46] botnet c&c traffic and flow lifespans using survival analysis

[47] «esa corporeidad mortal y rosa»: análisis del tiempo libre de enfermedad del cáncer de mama en gipuzkoa en presencia de riesgos competitivos "that deadly and pink corporeity": analysis of disease-free survival analysis in breast cancer in gipuzkoa (spain) in the presence of competing risks

[48] [download] (2154)the rcmdrplugin.survival package: extending the r commander interface to survival analysis

[49] Use of Survival Analysis to Determine the Postincubation Time-to-Death of Papaya Due to Yellow Crinkle Disease in Australia

[50] DeepMMSA: A Novel Multimodal Deep Learning Method for Non-small Cell Lung Cancer Survival Analysis